Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for quantifying number of cells of bacterium in sample

A technology of bacterial counts and samples, applied in biochemical equipment and methods, microbial determination/inspection, recombinant DNA technology, etc.

Pending Publication Date: 2020-09-18
MITSUI CHEM INC +1
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, pathogenic bacteria in patient test samples are often small in number, and thus sufficient sensitivity for accurate quantification may not be achieved in normal real-time PCR.
In addition, even if sufficient sensitivity is obtained, there is a problem that contamination is easily detected in bacterial universal PCR (a PCR that detects almost all bacteria), which creates difficulties in determining pathogenic bacteria
As a result, the quantitative examination of pathogenic bacteria in patient samples is very useful for the treatment of infectious diseases, but it has not yet been put into practical use due to technical unsolved problems

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for quantifying number of cells of bacterium in sample
  • Method for quantifying number of cells of bacterium in sample
  • Method for quantifying number of cells of bacterium in sample

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0081] (Preparation of nucleic acid samples derived from tested samples)

[0082] The preparation of the nucleic acid sample derived from the test sample can be performed by a conventional method.

[0083] It should be noted that the preparation of the nucleic acid sample derived from the test sample preferably uses a collection and nucleic acid extraction method that does not cause differences due to bacterial species as in the method used in the examples described later.

[0084] As the test sample, not only blood, but also cerebrospinal fluid (bacterial meningitis), pericardial effusion (pericarditis), pleural effusion (pleurisy), ascites (peritonitis), joint effusion (orthopedic postoperative infection) Symptoms), aqueous humor (endophthalmitis), pulmonary lavage fluid (pneumonia), urine (urinary tract infection), postoperative drainage tube drainage (postoperative infection), CV catheter tip (long-term bedridden patients) The sepsis caused by the catheter tip biofilm (Biofilm),...

Embodiment 1

[0252] figure 1 The relationship and flow of each step in this embodiment are shown.

[0253] (Step 1: Collection of bacteria and DNA extraction methods that do not produce differences caused by bacterial species)

[0254] First, in the collection of bacteria from the blood test sample, the whole blood is lightly centrifuged at 100×g for 5 minutes. After the blood cells are separated, the supernatant (including the supernatant) obtained by strong centrifugation at 20,000×g for 10 minutes The buffy coat) is granulated to collect bacteria. In this process, the fractionation of bacteria in the plasma did not change, and there was no difference in collection efficiency due to bacterial species.

[0255] To confirm this, Escherichia coli (E.coli ATCC25922), Staphylococcus aureus (S.aureus ATCC29213), Klebsiella pneumoniae (K.pneumoniae NBRC3512), and Pseudomonas aeruginosa were dissolved in saline. (P.aeruginosa ATCC27853), after light centrifugation at 100×g for 5 minutes, the upper ha...

Embodiment 2

[0367] Using steps 1 to 4 of Example 1, a rapid quantitative inspection of pathogenic bacteria was performed using a sepsis patient test sample (2 mL of EDTA blood collection tube). The cases are three cases in which sepsis was suspected at the Toyama University Hospital and the blood culture test was positive afterwards. Blood sampling is performed before antimicrobial treatment (pretreatment), 24 hours after antimicrobial administration (after24hrs.) and 72 hours after antimicrobial administration (after 72hrs.), and rapid quantitative inspection of pathogenic bacteria is performed at these 3 time points At the same time, body temperature, white blood cell count, CRP, Presepsin, and IL-6 were also measured. In addition, the identification of pathogenic bacteria and drug susceptibility test based on blood culture method were carried out on the test samples obtained by blood sampling before antibacterial treatment. The outline of each case is as follows.

[0368] Case 1:

[0369...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention addresses the problem of providing a method whereby it becomes possible to quantify the number of cells of a bacterium in a sample rapidly and with high accuracy by employing PCRmethod. A method which can solve the problem is a method in which the identification and quantification of bacterial cells in a sample are performed through the following steps: (1) a first PCR stepof carrying out PCR method using nucleic acid derived from the sample as a template and also using a universal primer pair for the amplification of 16S rRNA gene in the bacterium to obtain a first amplification product; (2) a second PCR step of carrying out nested PCR method using a primer pair for the amplification of an internal sequence in a sequence occurring in the first amplification productobtained in the first PCR step to produce a second amplification product; and (3) a cell number quantification step of determining the number of cells of the bacterium in the sample from the quantityof the second amplification product obtained in the second PCR step using data for calibration use. In addition to the steps (1) to (3), the following steps (4) and (5) may be additionally carried out: (4) a bacterial species identification step of identifying the species of the bacterium in the sample; and (5) the bacterial cell number correction step of employing the number of cells, which hasbeen obtained in the cell number quantification step, as a provisional number of the cells of the bacterium, and correcting the provisional number of cells on the basis of the number of copies of a 16S rRNA operon of each of the control bacterium and the bacterial species identified in the bacterial species identification step to determine the number of the cells in the sample.

Description

Technical field [0001] The present invention relates to a method for quickly and accurately quantifying the number of bacteria in a test sample, particularly a blood test sample, or quantifying the number of bacteria and identifying bacterial species using the PCR method. Background technique [0002] The traditional examination items used to determine the severity of sepsis are blood culture, endotoxin, procalcitonin, white blood cell count, CRP (C-reactive protein, C-reactive protein), blood pressure, body temperature, respiratory rate, pulse rate, etc. , Recently added Presepsin (soluble CD14 subtype, sCD14-ST). Because blood culture results take time, it is difficult to feed back into early treatment. Since the white blood cell count and CRP are the host's infection defense response, there is a time difference between the test value and the severity of the disease, which often deviates from the actual severity. Procalcitonin is difficult to apply in terms of specificity and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/09C12Q1/689
CPCC12Q1/689C12Q1/686
Inventor 仁井见英树北岛勋宫腰晃央东祥嗣
Owner MITSUI CHEM INC